ARCHIVES

NSABP’s B-14 Study Reports Deaths From Uterine Cancer Related To Tamoxifen

This article is from The Cancer Letter archive.

Vol. 20 No. 08 | February 25, 1994

Download PDF Visit The Full Archive

Related Articles

FDA Committee nixes Combination Guidelines, Okays New NDA Policy

January 21, 1977

Hormone Therapy Can Reduce Survival In Men With Heart Problems

August 26, 2011

Halterman, Mahoney And Their Grants Go To DCT, Along With Some Program Projects

March 17, 1978

New Model For Risk Assessment Includes Alcohol, Exercise, Weight

July 29, 2011

Conversation with The Cancer Letter: UT System Vice Chancellor Shine Describes Rationale for Granting Waiver to DePinho

October 26, 2012

Guest Editorial: As Sequestration Becomes More Likely, Health Groups Must Make Themselves Heard

February 22, 2013